This video reviews pseudoprogression in non–small-cell lung cancer, including the incidence of this phenomenon and treatment considerations when it arises.
In this video, Dickran Kazandjian, MD, of the National Institutes of Health in Bethesda, Maryland, reviews pseudoprogression in non–small-cell lung cancer, including the incidence of this phenomenon, identifying pseudoprogression from true progression, and treatment considerations when it does arise.
Kazandjian gave a presentation on this subject at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, held last month in Chicago.
Eric Ko on Combining Radiation Therapy With Immunotherapy to Treat Non–Small-Cell Lung Cancer
September 18th 2018ONCOLOGY spoke with Eric Ko, MD, PhD, who recently published a review article with his colleagues on strategies for combining radiation therapy with immunotherapy for the treatment of non–small-cell lung cancer.